This article was originally published in The Rose Sheet
July 29 single session of the FDA advisory committee continues to be scheduled for discussion of effectiveness testing for final formulations of health care antiseptic drug products under the Health Care Continuum Model, last reviewed by the group Jan. 22, 1997 ("The Rose Sheet" Feb. 3, 1997, pp. 3). The meeting, to be held at the Bethesda Holiday Inn, will be open from 1-2 p.m. Previously, the committee was slated for a three-day meeting, but the other OTC topics have been shuffled to later dates...
You may also be interested in...
With a push from the Organic Consumers Association, the National Organic Standards Board is recommending that the use of nanotechnology be strictly prohibited from products certified under the National Organic Program
Though global market-size estimates differ, analysts at SupplySide West 2010 in Las Vegas agreed that cosmeceuticals remain a promising growth vehicle
Weekly Trademark Review